Michael Q. Zhang | bioRxiv Science

bioRxiv2020

Characterizing microRNA-mediated modulation of gene expression noise and its effect on synthetic gene circuits

Gene expression noise plays an important role in many biological processes, such as cell differentiation and reprogramming. It can also dramatically influence the behavior of synthetic gene circuits. MicroRNAs (miRNAs) have been shown to reduce the noise of lowly expressed genes and increase the noise of highly expressed genes, but less is known about how miRNAs with different properties may regulate gene expression noise differently. Here, by quantifying gene expression noise using mathematical modeling and experimental measurements, we showed that competing RNAs and the composition of miRNA response elements (MREs) play important roles in modulating gene expression noise. We found that genes targeted by miRNAs with weak competing RNAs show lower noise than those targeted by miRNAs with strong competing RNAs. In addition, in comparison with a single MRE, repetitive MREs targeted by the same miRNA suppress the noise of lowly expressed genes but increase the noise of highly expressed genes. Additionally, MREs composed of different miRNA targets could cause similar repression levels but lower noise compared with repetitive MREs. We further observed the influence of miRNA-mediated noise modulation in synthetic gene circuits which could be applied to classify cell types using miRNAs as sensors. We found that miRNA sensors that introduce higher noise could lead to better classification performance. Our results provide a systematic and quantitative understanding of the function of miRNAs in controlling gene expression noise and how we can utilize miRNAs to modulate the behavior of synthetic gene circuits.

systems biology↗

bioRxiv2016

Recurrently deregulated lncRNAs associated with HCC tumorigenesis and metastasis revealed by genomic, epigenomic and transcriptomic profiling in paired primary tumor and PVTT samples

Hepatocellular carcinoma (HCC) are highly potent to invade the portal venous system and subsequently develop into the portal vein tumor thrombosis (PVTT). PVTT could induce intrahepatic metastasis, which is closely associated with poor prognosis. A comprehensive systematic characterization of long noncoding RNAs (lncRNAs) associated with HCC metastasis has not been reported. Here, we first assayed 60 clinical samples (matched primary tumor, adjacent normal tissue, and PVTT) from 20 HCC patients using total RNA sequencing. We identified and characterized 8,603 novel lncRNAs from 9.6 billion sequenced reads, indicating specific expression of these lncRNAs in our samples. On the other hand, the expression patterns of 3,212 known and novel recurrently deregulated lncRNAs (in >=20% of our patients) were well correlated with clinical data in a TCGA cohort and published liver cancer data. Some lncRNAs (e.g., RP11-166D19.1/MIR100HG) were shown to be useful as putative biomarkers for prognosis and metastasis. Moreover, matched array data from 60 samples showed that copy number variations (CNVs) and alterations in DNA methylation contributed to the observed recurrent deregulation of 716 lncRNAs. Subsequently, using a coding-noncoding co-expression network, we found that many recurrently deregulated lncRNAs were enriched in clusters of genes related to cell adhesion, immune response, and metabolic processes. Candidate lncRNAs related to metastasis, such as HAND2-AS1, were further validated using RNAi-based loss-of-function assays. The results of our integrative analysis provide a valuable resource regarding functional lncRNAs and novel biomarkers associated with HCC tumorigenesis and metastasis.

Genomics↗